|
|
|
| Observation on the Clinical Efficacy of Stereotactic Minimally Invasive Surgery Combined with Piracetam and Hyperbaric Oxygen in the Treatment of Brain Tumors |
| TANG Tao |
| The Affiliated Hospital of Yan'an University, Shaanxi Yan'an 716000,China |
|
|
|
|
Abstract Objective: To analyze the clinical efficacy of stereotactic micro-invasive surgery combined with postoperative piracetam and hyperbaric oxygen therapy for brain tumors. Methods: 104 cases of brain tumor patients were divided into control group and observation group according to admission by random digital table method, each group of 52 cases. The control group was treated with stereotactic minimally invasive surgery. The observation group was given stereotactic minimally invasive surgery combined with piracetam and hyperbaric oxygen therapy. The quality of life score, adverse reactions, curative effect and survival rate, mortality, recurrence rate and metastasis rate during the 1-year follow-up were and compared between the two groups. Results: During treatment, the total incidence of complications in the observation group was 7.67%, The mortality, recurrence rate and metastasis rate were 11.54%, 1.92%, 1.92% during follow-up, respectively, and these were significantly lower than the control group's (21.15%, 19.23%, 13.46%, 13.46%) (all P<0.05). After treatment, the total score of the life quality in the observation group was (89.04±7.78), the total effective rate was 92.31%, and the survival rate was 90.38%, which were significantly higher than those in the control group (69.17±6.74, 78.85%, 53.85%) (all P<0.05) . Conclusion: The effect of Laci Staw and hyperbaric oxygen therapy on brain tumor patients after minimally invasive surgery is significant. It can effectively improve the quality of life, reduce the incidence of complications, and have high safety.
|
|
|
|
|
|
[1] 李学军,曹航,LIU Yanhong.脑肿瘤遗传流行病学及危险因素研究进展[J].中南大学学报:医学版,2018,43(4):345~353.
[2] Leon S P, Folkerth R D, Black P M. Microvessel density is a prognostic indicator for patients with astroglial brain tumors.[J]. Cancer, 2015, 77(2):362~372.
[3] 缪学建,宋志富,庞国银,等.八珍汤联合通窍活血汤辅助治疗脑肿瘤术后气虚血瘀证的临床观察[J].中国实验方剂学杂志,2016,22(10):175~179.
[4] 王鹏,林涛,车海江.联合药物方案辅助治疗对脑动脉瘤栓塞术后脑血管痉挛患者GCS评分、生活质量及脑梗死发生率影响[J].临床军医杂志,2017,45(2):200~202.
[5] 刘冰.磁共振成像引导颅内肿瘤微创治疗的优劣分析[J].中国肿瘤临床,2016,43(11):467~470.
[6] 陈丽欢,邓丽芳,钟秀珍,等.支持性心理治疗对脑肿瘤术后病人的抑郁状态及生活质量的影响[J].全科护理,2017,15(5):577~579.
[7] 朱文锐,田俊.参芪扶正注射液对脑肿瘤手术患者术后临床疗效及免疫功能的影响[J].中医药导报,2016,22(4):39~41.
[8] 周路阳,顾伟,刘芸,等.右美托咪定对脑肿瘤手术患者细胞免疫功能以及预后影响的研究[J].现代生物医学进展,2017,17(28):5484~5488.
[9] 赵四军,赵明,徐欣,等.脑肿瘤患者术后颅内感染病原学特点及危险因素分析[J].中华医院感染学杂志,2017,27(21):4916~4918,4934.
[10] 霍贵通,王少青,闫君蕊,等.立体定向微创手术联合术后高压氧及吡拉西坦治疗脑肿瘤对患者生活质量的影响[J].临床合理用药,2016,9(1):119~121.
[11] 黄志刚.高血压基底节区脑出血患者微创术后应用神经生长因子的效果观察[J].河北医学,2016,22(6):910~913.
[11] 余良宏,康德智,何理盛,等.CT-脑立体定向手术的临床应用[J].福建医科大学学报,2012,2(36):176~177.
[12] 匡静,冯婷,郑佳,等.手术后高压氧加放疗治疗脑瘤的疗效[J].中国肿瘤临床与康复,2015,22(3):323~325.
[13] 王恩阳,徐飞,贾明轩.应用千伏级锥形束CT对非小细胞肺癌立体定向放疗PTV外放边界研究[J].中国CT和MRI杂志,2016,14(2):37~39.
[14] 刘胜美,黄权,阮珍义,等.立体定向微创手术联合吡拉西坦治疗脑肿瘤的临床疗效[J].中国肿瘤临床与康复,2016,23(9):1079~1081. |
| [1] |
. [J]. HeBei Med, 2018, 24(8): 1392-1393. |
|
|
|
|
2018, Vol. 24 
